2017
DOI: 10.1016/j.ijcard.2017.09.157
|View full text |Cite
|
Sign up to set email alerts
|

Fibrinogen levels compensation of thrombocytopenia-induced bleeding following cardiac surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 16 publications
0
14
0
2
Order By: Relevance
“…There was an improvement in all coagulation test parameters at Time 2 with the exception of fibrinogen levels, which decreased slightly (241 ± 54 to 236 ± 47 mg/dL). Prior investigations have described this observation but the mechanism may be secondary to release of sequestered coagulation factors and platelets following CPB 20,21 . Knowledge of this “normalization” may help guide clinicians in their management of abnormal coagulation tests in the absence of ongoing surgical bleeding.…”
Section: Discussionmentioning
confidence: 93%
“…There was an improvement in all coagulation test parameters at Time 2 with the exception of fibrinogen levels, which decreased slightly (241 ± 54 to 236 ± 47 mg/dL). Prior investigations have described this observation but the mechanism may be secondary to release of sequestered coagulation factors and platelets following CPB 20,21 . Knowledge of this “normalization” may help guide clinicians in their management of abnormal coagulation tests in the absence of ongoing surgical bleeding.…”
Section: Discussionmentioning
confidence: 93%
“…The up-regulation of coagulation factors II (prothrombin) (P00734), V (P12259), IX (P00740), X (P00742) and XII (P00748) observed in the GDM group as compared to uncomplicated pregnancies suggests an exaggeration of the existing hyper-coagulation state associated with pregnancy (16). The list was accompanied by the altered expression of all three fibrinogen-polypeptide chains [α (P02671), β (P02675) and γ (P02679)] probably due to a common thrombocytosis state in the GDM patients (17,18). Complement C3 (P01024), an important player in the activation of the complement system, in both, classical and alternative pathways, was found moderately overexpressed in the present study emphasizing the essential role of the immune system activation in the pathogenesis of GDM.…”
Section: Discussionmentioning
confidence: 95%
“…Therefore, the first target in our cardiovascular algorithm is an A5 FIB ≥ 12 mm (fibrinogen concentration ≥ 2.5 g/L) and the second target (if bleeding continues in complex cardiovascular surgery) is an A5 FIB ≥ 15 mm (fibrinogen concentration ≥ 3 g/L). An A5 FIB ≥ 12 mm (fibrinogen concentration ≥ 2.5 g/L) may compensate for thrombocytopenia (< 100/nl) or platelet dysfunction after CPB [53,70]. The dose calculation for fibrinogen concentrate or cryoprecipitate are based on the targeted increase in FIBTEM amplitude and presented in Table 2 [46,53,66,71,72].…”
Section: Korean J Anesthesiolmentioning
confidence: 99%